Langgaman, Jevie S.

HRN: 13-45-37  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/01/2024
CEFUROXIME 750MG (VIAL)
11/01/2024
11/08/2024
IV
600mg
Q8hours
PCAP-B
Waiting Final Action 
11/01/2024
CEFTRIAXONE 1G (VIAL)
11/01/2024
11/08/2024
IV
1.8g
Q24hours
Typhoid Fever; PCAP-B
Waiting Final Action 
11/03/2024
CEFTRIAXONE 1G (VIAL)
11/03/2024
11/08/2024
IV
900mg
Q12hours
Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: